Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX)

CUSIP: G9495L125

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary shares, par value $0.001 per share
Shares outstanding
8,247,337
Total 13F shares
34,959
Share change
-59,850
Total reported value
$12,085
Price per share
$0.35
Number of holders
5
Value change
-$41,527
Number of buys
4
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G9495L125?
CUSIP G9495L125 identifies VRAX - Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX) as of Q4 2025

As of 31 Dec 2025, Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,959 shares. The largest 5 holders included XTX Topco Ltd, UBS Group AG, NATIONAL BANK OF CANADA /FI/, OSAIC HOLDINGS, INC., and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.